(1) primary, (2) secondary, (3) secondary to multiple myeloma, and (4) localised masses. At that time the localised form was known to affect the eye, bladder, urethra, pharynx, tongue, and respiratory tract.3
The first report of amyloid localised to the lower respiratory tract was by Lesser in 1877.4 Subsequent sporadic reporting of respiratory amyloid has led to the use of many classifications and descriptive titles. A further complication is the fact that many subgroups of respiratory amyloid exist and there are important differences in presenting symptoms, signs, prognosis, and management. Prowse,5 Weiss, 6 Spencer,7 Wilson et al, 8 Himmelfarb et Although there are only a few specific reviews of reports of pulmonary lesions in primary generalised amyloidosis, most patients apparently have deposits in the lower respiratory tract." Histologically these are similar to those seen in the localised diffuse alveolar septal form, except for a few cases which have been reported as having pulmonary nodules.4 1213 Secondary generalised amyloid can similarly affect the lower respiratory tract but it is less common and infiltrates the lung to a lesser extent. This is confirmed clinically as it is extremely rare for patients with generalised secondary amyloidosis to have any respiratory symptoms and the chest radiograph is usually normal. Primary generalised amyloidosis provokes an inflammatory response in the surrounding lung tissue while this is unusual in the secondary form. '4 In reviewing localised pulmonary amyloid we excluded any cases with demonstrable lesions in non-respiratory sites4 1213 and any which were reported twice by different authors.'2 ' plaques of amyloid are seen as ridges and stenoses and are shiny and pale owing to stretching of the overlying surface epithelium. The chest radiograph may be normal or show areas of atelectasis secondary to obstruction by amyloid lesions that are distributed radially along the proximal airways. As a result the patients frequently suffer from repeated episodes of bronchial infection and may eventually develop areas of bronchiectasis, leading to further confusion in diagnosis.5 24 32 In contrast, the endobronchial tumour-like masses are usually polypoid and solitary and occur only in the major bronchi. As a result the clinical features, radiographic changes, and macroscopic appearance at bronchoscopy may be indistinguishable from those of an endobronchial neoplasm. 29 Local biopsies or total resection, or both, as well as a vigilant histology department may be needed to make the correct diagnosis.
Patients with parenchymal lung nodules are usually referred to the physician because of an incidental finding on their chest radiograph. Occasionally they have symptoms which are attributable to the mechanical effects of a large pulmonary mass. The pulmonary nodules are usually peripheral and subpleural and range in size from 1 to 15 cm in diameter. They grow slowly, may be solitary or multiple, and may affect both lungs at the same time. Up to one-third of the nodules cavitate or have calcification, adding to the difficulties of making a radiological diagnosis.91032 It may also be difficult to make a histological diagnosis as a few nodules have been described as being lamellated and granulomatous. "6 In the nodular (and diffuse) pulmonary form needle aspiration and transbronchial biopsies provide relatively non-invasive methods of diagnosis. 33 34 Surgical resection, however, is often needed to obtain a satisfactory result.
Although the group of patients with diffuse pulmonary lesions may also present with an abnormal chest radiogra'ph they more frequently complain of increasing dyspnoea with no obvious cause. They may have basal lung crepitations as their only clinical sign but occasionally there is an associated pleural effusion. The radiographic abnormalities and clinical features are frequently confused with those of pulmonary oedema, of both cardiac and non-cardiac origin, and with pulmonary fibrosis. The diagnosis is most frequently obtained at necropsy and microscopic sections show the amyloid tissue to be deposited in alveolar walls and septa as well as around pulmonary arterioles.'0 26 37 The effectiveness of treatment for pulmonary amyloid depends on the type. With tracheobronchial submucosal plaques, repeated treatment with bronchoscopic piecemeal resections is usually needed.27 Cure is rarely achieved and severe haemoptysis is a common complication. 28 In this respect the use of bronchoscopic laser cautery may eventually prove to be a better form of treatment. Recurrence after excision of isolated masses, whether they are endobronchial or pulmonary nodules, is very rare and this is therefore the treatment of choice.35 In view of the relatively benign nature of the pulmonary nodules, however, careful observation may be all that is required if histological examination has group.bmj.com on May 3, 2017 -Published by http://thorax.bmj.com/ Downloaded from already provided evidence of amyloid without total resection. This course would not be wise for a solitary nodule as it would be difficult to differentiate it from a neoplasm producing amyloid. In amyloidosis many other forms of treatment have been used, including corticosteroids, immunosuppressants, colchicine, and radiotherapy. In respiratory amyloid they have been used particularly in the management of tracheobronchial plaques and alveolar septal infiltrations, but with only limited success.26363747 Newer approaches to treatment have concentrated on drugs that break down the amyloid fibrils.
Amyloid consists of a matrix of fibrillary proteins whose unique staining properties with congo red and green birefringence with polarised light are due to the structural arrangement of the fibrils in twisted beta-pleated sheets.' All forms of amyloid have this basic structure but the protein fibrils differ chemically. At least two major subunit proteins of amyloid, AA and AL, can be distinguished by immunochemical methods. Proteolysis of a serum acute-phase protein, SAA, is thought to produce protein AA, which is the major constituent of secondary amyloid. Protein AL, similarly derived but from immunoglobulin light chains, is found in primary amyloid, amyloid secondary to multiple myeloma, and the form associated with familial Mediterranean fever. [48] [49] [50] [51] Despite the identification of these different proteins, the pathogenesis of both generalised and localised amyloidosis is unknown. We do not know whether the deposition of protein follows excess production, defective clearance, or a combination of both. 48 
